Long-term effectiveness of acetazolamide on permanent weakness in hyperkalemic periodic paralysis.

Abstract excerpt

Acetazolamide is commonly used as an empirical treatment for inherited periodic paralyses although some patients may develop deleterious effects. We report a 65 year-old man with hyperkalemic periodic paralysis and late-onset permanent weakness in association with the common T704M mutation in α-subunit, skeletal muscle voltage-gated sodium channel gene. He rapidly recovered from weakness after acetazolamide...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aged
• Share to Muscle Weakness